AUS
NZ
UK
CA
USA
IND
TZ Limited (ASX:TZL) has submitted an application to list 4,042,731 new ordinary fully paid shares on the ASX. These shares were issued on 15 July 2026 at $0.03 each as part of a previously announced non-renounceable pro rata entitlement rights issue. This follows the Appendix 3B filing made on 16 June 2026 that initially revealed the planned securities issuance. The company’s directors and lead manager retain the option to place a significant shortfall of up to 81,925,404 shares within three months after the rights issue closed on 9 July 2026. Upon quotation of these new shares, TZ Limited’s total quoted ordinary fully paid shares will increase to 364,583,500.
Key Points
- TZ Limited (ASX:TZL) has applied for ASX quotation of newly issued ordinary fully paid shares.
- 4,042,731 shares were issued at $0.03 per share on 15 July 2026 as part of a non-renounceable pro rata entitlement rights issue announced on 16 June 2026.
- Directors and the lead manager may place up to 81,925,404 shortfall shares within three months after the 9 July 2026 closing date; total shares on issue will reach 364,583,500 after quotation.
- Investors should monitor if the shortfall placement is exercised and its potential impact on the company’s capital structure.
Overview of TZ Limited's Non-Renounceable Entitlement Rights Issue and Appendix 3B Announcement
The newly applied-for shares are part of a capital raising process first disclosed on 16 June 2026, when TZ Limited lodged an Appendix 3B titled "New – Proposed issue of securities – TZL." This filing outlined the company’s plan to conduct a standard pro rata non-renounceable entitlement issue, establishing the regulatory framework for issuing the 4,042,731 ordinary fully paid shares now applied for quotation. The Appendix 2A application submitted on 15 July 2026 formalizes the listing of these securities on the ASX, confirming they were issued under the previously announced transaction.
A non-renounceable entitlement issue allows eligible shareholders to subscribe for new shares proportionate to their holdings, but the rights cannot be sold or transferred if not exercised. Shareholders who did not participate received no value for their unexercised rights. The offer closed on 9 July 2026, marking the start of a three-month window during which the company may place any shortfall shares. The total capital raised was not disclosed in this update.
Details on the $0.03 Issue Price and Its Impact on TZ Limited’s Share Capital
The 4,042,731 new shares were issued at $0.03 each, which is also the price at which the directors and lead manager may place shortfall shares. At this price, the gross proceeds from this tranche amount to approximately $121,282, although the company did not specify total funds raised in this update. Investors should consult prior disclosures for comprehensive fundraising details.
This issue price is important for shareholders evaluating dilution effects. With the total quoted shares rising to 364,583,500 after this quotation, the capital base remains substantial relative to the new shares issued. Additionally, TZ Limited has unquoted options outstanding: 215,000 TZLAQ options expiring at various dates and prices, and 46,200,000 TZLAA options expiring 20 May 2029 at an exercise price of $0.05, which could cause further dilution if exercised.
Significance of the 81,925,404 Shortfall Shares and Placement Rights
A key point in this update is the shortfall of 81,925,404 shares from the entitlement issue. The directors and lead manager have the discretion to place these shares within three months following the 9 July 2026 closing date, until approximately 9 October 2026. This large shortfall indicates many eligible shareholders did not take up their entitlements.
If fully placed at $0.03 each, these shortfall shares could raise around $2,457,762 in gross proceeds and result in additional dilution. The company did not disclose this figure explicitly. Investors should watch for further announcements regarding whether the shortfall placement will be partially or fully exercised.
Total Quoted Shares Increase to 364,583,500 Ordinary Fully Paid Shares
After listing the 4,042,731 new shares, TZ Limited’s total quoted ordinary fully paid shares will reach 364,583,500, as confirmed in Part 4 of the Appendix 2A filing. This total excludes any shares that may be issued from the shortfall placement, which remains subject to future decisions by the directors and lead manager.
The increase in shares reflects the company’s capital raising efforts via equity markets. The update does not specify the intended use of proceeds or provide guidance on financial or operational outlook. Shareholders seeking further details should review earlier disclosures including the original Appendix 3B and offer documents lodged in June 2026.
Unquoted Options: TZLAA and TZLAQ Classes and Potential Dilution
TZ Limited’s capital structure includes unquoted options outside the quoted share count but relevant for dilution analysis. The TZLAQ class consists of 215,000 options with various expiry dates and exercise prices, while the TZLAA class includes 46,200,000 options expiring 20 May 2029 at a $0.05 exercise price. These options are not traded on the ASX.
If all TZLAA options were exercised, they would generate $2,310,000 in gross proceeds and add 46,200,000 shares to the register, significantly increasing the share base. Exercise depends on market conditions and share price performance relative to $0.05 before expiry. No further details on vesting, holders, or exercise timelines were provided.
About TZ Limited and Its ASX Listing
TZ Limited is an Australian company listed on the ASX under ticker TZL with ABN 26 073 979 272. The company has engaged in capital raising through this non-renounceable entitlement rights issue, applying for quotation of securities denominated in Australian dollars. The Appendix 2A filing confirms compliance with ASX Listing Rules governing new securities quotation.
This announcement does not provide detailed information on TZ Limited’s business operations, revenue streams, products, or geographic reach. Investors seeking comprehensive insights should consult the company’s broader ASX disclosures, including annual reports and investor presentations. The immediate share price impact of this update was not evident from public information.
Regulatory Process Behind the Appendix 2A Quotation Application
Submitting an Appendix 2A is the standard ASX regulatory process for applying to quote new securities. By lodging this form, TZ Limited confirms adherence to the ASX Listing Rules and procedural requirements for listing the 4,042,731 new shares. These shares are ordinary fully paid, denominated in Australian dollars, and carry the existing ASX code TZL, ranking equally with existing shares.
The distribution schedule section of the Appendix 2A, which normally details shareholder numbers and holding sizes, was not completed in this filing. Thus, the allocation of new shares across shareholder categories is not disclosed. Investors seeking this data should monitor future disclosures or contact the company’s share registry. The Appendix 2A was lodged on 15 July 2026, matching the issue date.
Key Dates Timeline for TZ Limited’s Entitlement Issue
The entitlement issue timeline started on 16 June 2026 with the Appendix 3B announcement of the securities offering. The rights issue closed on 9 July 2026, establishing the three-month window for shortfall placement. The 4,042,731 shares were issued and the Appendix 2A lodged on 15 July 2026, six days after closing.
This timeline reflects a swift progression from rights issue close to quotation application. The shortfall placement right expires around 9 October 2026, giving the directors and lead manager a defined period to place up to 81,925,404 shares. Investors should consider this schedule when evaluating potential share register changes and upcoming catalysts over the next quarter.
